Burning Rock Biotech Ltd (NASDAQ:BNR)

2.50
Delayed Data
As of Jun 02
 -0.08 / -3.10%
Today’s Change
1.70
Today|||52-Week Range
4.24
+11.11%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Burning Rock Biotech Ltd have a median target of 3.84, with a high estimate of 8.65 and a low estimate of 3.74. The median estimate represents a +53.78% increase from the last price of 2.50.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Burning Rock Biotech Ltd. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.37
Sales
$173.0M
Reporting Date
Aug 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.31%
 
 
 
 
 
 
Growthannually 52.67%
 
 
 
 
 

Sales

Growthquarterly 21.39%
 
 
 
 
 
 
Growthannually 20.69%
 
 
 
 
 
Key to the earnings and sales forecast charts.